OTCMKTS:IAGX

Imagenetix Stock Forecast, Price & News

$0.0020
0.00 (-31.03 %)
(As of 08/30/2021)
Add
Compare
Today's Range
$0.00
▼
$0.00
50-Day Range
$0.00
▼
$0.02
52-Week Range
$0.00
▼
$0.02
Volume140,000 shs
Average Volume98,981 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.29
30 days | 90 days | 365 days | Advanced Chart
Receive IAGX News and Ratings via Email

Sign-up to receive the latest news and ratings for Imagenetix and its competitors with MarketBeat's FREE daily newsletter.


About Imagenetix

Imagenetix, Inc. develops, formulates and markets over-the-counter and natural-based nutritional supplements and skin care products. It concentrates on two medical need areas, including human and animal conditions related to inflammation and obesity. The company was founded in March 1988 and is headquartered in San Diego, CA.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Imagenetix (OTCMKTS:IAGX) Frequently Asked Questions

What stocks does MarketBeat like better than Imagenetix?

Wall Street analysts have given Imagenetix a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Imagenetix wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Imagenetix's key executives?

Imagenetix's management team includes the following people:
  • Decky Goodrich, President & Chief Executive Officer
  • Lowell W. Giffhorn, Chief Financial Officer & Secretary
  • William P. Spencer, Chief Technology Officer

Who are some of Imagenetix's key competitors?

Some companies that are related to Imagenetix include Acusphere (ACUS), Affymax (AFFY), ARYx Therapeutics (ARYX), AtheroNova (AHROQ), China Botanic Pharmaceutical (CBPI), China Dongsheng International (CDSG), Diadexus (DDXSQ), ERBA Diagnostics (ERBA), Interpharm (IPAH), Inyx (IYXI), IR Biosciences (IRBS), Miravant Medical Technologies (MRVT), Myrexis (MYRX), Nanobac Pharmaceuticals (NNBP) and Pivotal Therapeutics (PVTTF).
View all of IAGX's competitors.

What is Imagenetix's stock symbol?

Imagenetix trades on the OTCMKTS under the ticker symbol "IAGX."

How do I buy shares of Imagenetix?

Shares of IAGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Imagenetix's stock price today?

One share of IAGX stock can currently be purchased for approximately $0.00.

How many employees does Imagenetix have?

Imagenetix employs 4 workers across the globe.

What is Imagenetix's official website?

The official website for Imagenetix is www.imagenetix.net.

Where are Imagenetix's headquarters?

Imagenetix is headquartered at 16935 WEST BERNARDO DRIVE SUITE 101, SAN DIEGO CA, 92127.

How can I contact Imagenetix?

Imagenetix's mailing address is 16935 WEST BERNARDO DRIVE SUITE 101, SAN DIEGO CA, 92127. The company can be reached via phone at (858) 674-8455.


This page was last updated on 9/20/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.